AstraZeneca plc (LON:AZN)‘s stock had its “reduce” rating reissued by Kepler Capital Markets in a report released on Monday, Marketbeat.com reports. They currently have a GBX 3,700 ($55.08) target price on the biopharmaceutical company’s stock. Kepler Capital Markets’ price target suggests a potential downside of 18.50% from the stock’s current price. AZN has been the […]
